Mark A. Longer
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 5
- Advanced Drug Delivery Systems 5
-
- Pharmaceutical studies and practices 3
- Co-authors
- Joseph R. Robinson (6 shared papers)Peter J. Gruber (2 shared papers)M. Veillard (3 shared papers)Thomas W. Martens (1 shared paper)Praveen Tyle (3 shared papers)Bhasker V. Shetty (2 shared papers)John W. Mauger (1 shared paper)John F. Woodley (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (2 papers)Advanced Drug Delivery Reviews (2 papers)Pharmaceutical Research (1 paper)International Journal of Pharmaceutics (1 paper)Annals of the New York Academy of Sciences (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Mark A. Longer
10 papers receiving 426 citations
Peers
Comparison fields: 5 of 76
- Pharmaceutical Science 316
- Drug Discovery 1
- Molecular Medicine 26
- Gastroenterology 28
- Virology 16
Countries citing papers authored by Mark A. Longer
This map shows the geographic impact of Mark A. Longer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Longer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Longer more than expected).
Fields of papers citing papers by Mark A. Longer
This network shows the impact of papers produced by Mark A. Longer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Longer. The network helps show where Mark A. Longer may publish in the future.
Co-authors
The 13 scholars most cited alongside Mark A. Longer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 147 | |
| 2 | 1987 | 79 | |
| 3 | 1988 | 66 | |
| 4 | 1987 | 63 | |
| 5 | 1987 | 36 | |
| 6 | 1995 | 35 | |
| 7 | 1996 | 20 | |
| 8 | 1989 | 10 | |
| 9 | 1991 | 10 | |
| 10 | 1995 | 2 |
About Mark A. Longer
Mark A. Longer is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health, Infectious Diseases, Virology and Nutrition and Dietetics, having authored 10 papers that have together received 468 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (5 papers), Pharmaceutical studies and practices (3 papers), HIV Research and Treatment (2 papers), Biochemical Analysis and Sensing Techniques (2 papers), HIV/AIDS drug development and treatment (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Nanofabrication and Lithography Techniques (1 paper). The work is most often cited by research in Pharmaceutical Science (316 citations), Drug Discovery (1 citation), Molecular Medicine (26 citations), Gastroenterology (28 citations) and Virology (16 citations). Mark A. Longer has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Joseph R. Robinson, Peter J. Gruber, M. Veillard, Thomas W. Martens, Praveen Tyle, Bhasker V. Shetty, John W. Mauger, John F. Woodley, Ruth Duncan and Jindřich Kopeček. Their work appears in journals such as Journal of Pharmaceutical Sciences, Advanced Drug Delivery Reviews, Pharmaceutical Research, International Journal of Pharmaceutics and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.